Gene Expression and Immunohistochemistry in Adipose Tissue of HIV Type 1–Infected Patients with Nucleoside Analogue Reverse-Transcriptase Inhibitor–Associated Lipoatrophy

Autor: Sievers, M., Walker, U. A., Sevastianova, K., Setzer, B., Wågsäter, D., Eriksson, P., Yki-Järvinen, H., Sutinen, J.

Publikováno v: The Journal of Infectious Diseases, 2009 Jul . 200(2), 252-262.

Externí odkaz: https://www.jstor.org/stable/40254990

CB1 blockade-induced weight loss over 48 weeks decreases liver fat in proportion to weight loss in humans.

Autor: Bergholm, R¹, Sevastianova, K¹, Santos, A¹, Kotronen, A¹, Urjansson, M¹, Hakkarainen, A², Lundbom, J², Tiikkainen, M¹, Rissanen, A³, Lundbom, N², Yki-Järvinen, H¹

Publikováno v: International Journal of Obesity. May2013, Vol. 37 Issue 5, p699-703. 5p.

The Clínica Universidad de Navarra-Body Adiposity Estimator index is a reliable tool for screening metabolic dysfunction-associated steatotic liver disease: an analysis from a gender perspective.

Autor: Wang, Chao^1,2 (AUTHOR), Huang, Xin^1,2 (AUTHOR), He, Shiming^1,2 (AUTHOR), Kuang, Maobin^1,2 (AUTHOR), Xie, Guobo^3,4 (AUTHOR), Sheng, Guotai^3,4 (AUTHOR) tgs200509@163.com, Zou, Yang² (AUTHOR) jxyxyzy@163.com

Publikováno v: Lipids in Health & Disease. 9/27/2024, Vol. 23 Issue 1, p1-11. 11p.

Metabolic, Mitochondrial, and Inflammatory Effects of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate in Asymptomatic Antiretroviral-Naïve People with HIV.

Autor: Barroso, Sergio^1,2,3 (AUTHOR) rafael.artuch@sjd.es, Guitart-Mampel, Mariona^1,2,3 (AUTHOR) mguitart@recerca.clinic.cat, García-García, Francesc Josep^1,2,3 (AUTHOR) fjgarcia@recerca.clinic.cat, Cantó-Santos, Judith^1,2,3 (AUTHOR) jcanto@recerca.clinic.cat, Valls-Roca, Laura^1,2,3 (AUTHOR) lvalls@recerca.clinic.cat, Andújar-Sánchez, Félix^1,2,3 (AUTHOR) fandujsa7@alumnes.ub.edu, Vilaseca-Capel, Adrià^1,2,3 (AUTHOR) avilasca9@alumnes.ub.edu, Tobías, Ester^1,2,3 (AUTHOR) etobiasb@ub.edu, Arias-Dimas, Angela⁴ (AUTHOR) angelayasmina.arias@sjd.es, Quesada-López, Tania^5,6 (AUTHOR) tquesada@ub.edu, Artuch, Rafael^3,4 (AUTHOR), Villarroya, Francesc^5,6 (AUTHOR) fvillarroya@ub.edu, Giralt, Marta^5,6 (AUTHOR) mgiralt@ub.edu, Martínez, Esteban^7,8 (AUTHOR) estebanmartinez@ub.edu, Lozano, Ester⁹ (AUTHOR) elozano@ub.edu, Garrabou, Glòria^1,2,3 (AUTHOR) elozano@ub.edu

Publikováno v: International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 15, p8418. 17p.

Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers.

Autor: Buzkova J; Research Programs Unit, Molecular Neurology, Biomedicum-Helsinki, University of Helsinki, Helsinki, Finland., Nikkanen J; Research Programs Unit, Molecular Neurology, Biomedicum-Helsinki, University of Helsinki, Helsinki, Finland., Ahola S; Research Programs Unit, Molecular Neurology, Biomedicum-Helsinki, University of Helsinki, Helsinki, Finland., Hakonen AH; Research Programs Unit, Molecular Neurology, Biomedicum-Helsinki, University of Helsinki, Helsinki, Finland., Sevastianova K; Department of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Minerva Foundation Institute for Medical Research, Helsinki, Finland., Hovinen T; Research Programs Unit, Molecular Neurology, Biomedicum-Helsinki, University of Helsinki, Helsinki, Finland., Yki-Järvinen H; Department of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Minerva Foundation Institute for Medical Research, Helsinki, Finland., Pietiläinen KH; Research Programs Unit, Diabetes and Obesity, Obesity Research Unit, University of Helsinki, Helsinki, Finland.; Abdominal Centre, Endocrinology, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland., Lönnqvist T; Department of Child Neurology, Children's Hospital, University of Helsinki, Helsinki, Finland., Velagapudi V; Metabolomics Unit, Institute for Molecular Medicine Finland FIMM, HiLIFE, University of Helsinki, Helsinki, Finland., Carroll CJ; Research Programs Unit, Molecular Neurology, Biomedicum-Helsinki, University of Helsinki, Helsinki, Finland.; Genetics Research Centre, Molecular and Clinical Sciences Institute, St. George's University of London, London, UK., Suomalainen A; Research Programs Unit, Molecular Neurology, Biomedicum-Helsinki, University of Helsinki, Helsinki, Finland anu.wartiovaara@helsinki.fi.; Department of Neurosciences, Helsinki University Hospital, Helsinki, Finland.; Neuroscience Centre, Helsinki Institute Life Science, University of Helsinki, Helsinki, Finland.

Publikováno v: EMBO molecular medicine [EMBO Mol Med] 2018 Dec; Vol. 10 (12).